Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery

Clinical trial NCT05126303 · TERMINATED

Trial details

NCT number: NCT05126303
Sponsor: Guard Therapeutics AB
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Kidney Injury

Start date: 2022-03-31
Primary completion: 2023-04-15
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.